1 line
3.1 KiB
JSON
1 line
3.1 KiB
JSON
{"acute generalised exanthematous pustulosis": 15.1, "acute kidney injury": 5.41, "acute respiratory distress syndrome": 12.87, "acute respiratory failure": 3.29, "adverse event": 2.69, "agranulocytosis": 3.36, "alanine aminotransferase increased": 3.12, "anaphylactic shock": 3.95, "antimicrobial susceptibility test resistant": 4322.06, "aspartate aminotransferase increased": 4.47, "bacteraemia": 17.53, "blood alkaline phosphatase increased": 4.53, "blood creatine phosphokinase increased": 100.09, "blood creatinine increased": 5.03, "blood lactate dehydrogenase increased": 2.07, "blood urea increased": 3.83, "c-reactive protein increased": 4.22, "candida infection": 4.38, "cardiac valve vegetation": 343.28, "cholestasis": 3.03, "clostridium difficile colitis": 7.06, "computerised tomogram abnormal": 28.83, "creatinine renal clearance decreased": 8.13, "crepitations": 23.99, "death": 2.52, "dermatitis exfoliative generalised": 6.25, "device related infection": 15.05, "disseminated intravascular coagulation": 4.84, "drug eruption": 3.65, "drug ineffective for unapproved indication": 18.4, "drug reaction with eosinophilia and systemic symptoms": 17.04, "drug resistance": 16.56, "drug-induced liver injury": 2.49, "embolism": 3.65, "encephalopathy": 2.06, "endocarditis": 50.79, "endocarditis staphylococcal": 346.24, "enterococcal bacteraemia": 248.42, "enterococcal infection": 62.8, "eosinophil count increased": 34.62, "eosinophilia": 62.75, "eosinophilic pneumonia": 1710.02, "eosinophilic pneumonia acute": 1641.17, "hepatic cytolysis": 4.91, "hepatic failure": 2.38, "hyperkalaemia": 5.58, "hypersensitivity pneumonitis": 53.61, "hypertransaminasaemia": 2.88, "hypoxia": 10.37, "impaired healing": 2.46, "infection": 2.91, "international normalised ratio increased": 7.8, "interstitial lung disease": 4.96, "leukocytosis": 2.48, "liver function test increased": 3.49, "lung consolidation": 29.79, "lung disorder": 6.21, "lung infiltration": 46.5, "mechanical ventilation": 14.09, "mental status changes": 5.23, "minimum inhibitory concentration": 1446.39, "multiple organ dysfunction syndrome": 7.93, "myoglobin blood increased": 29.99, "myopathy": 28.07, "myositis": 7.12, "nephropathy toxic": 4.52, "organising pneumonia": 21.15, "osteomyelitis": 20.85, "overdose": 5.8, "pancytopenia": 2.81, "pathogen resistance": 81.42, "platelet count decreased": 2.07, "pleural effusion": 2.06, "pneumonia": 2.18, "pneumonitis": 6.13, "product use in unapproved indication": 6.54, "pulmonary eosinophilia": 1631.98, "pulmonary toxicity": 10.84, "rales": 7.67, "rash maculo-papular": 3.42, "renal failure": 3.63, "renal impairment": 4.16, "renal tubular necrosis": 5.94, "respiratory distress": 2.93, "respiratory failure": 6.54, "rhabdomyolysis": 64.75, "sepsis": 5.12, "septic embolus": 63.59, "septic shock": 8.2, "staphylococcal bacteraemia": 166.02, "staphylococcal infection": 21.75, "staphylococcal sepsis": 11.72, "staphylococcus test positive": 26.6, "stevens-johnson syndrome": 4.3, "tachypnoea": 5.42, "toxic epidermal necrolysis": 5.11, "toxic skin eruption": 7.91, "treatment failure": 9.01, "tubulointerstitial nephritis": 8.24, "white blood cell count increased": 4.32} |